Work

Multisystem inflammatory syndrome in children (MIS-C) burden in India: A multicentre implementation research study

Year: 2026
Type: article
Study design: Observational Study
Abstract: Background Multisystem inflammatory syndrome in children (MIS-C) is a severe post-infectious complication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The condition has limited evidence and requires further exploration in countries such as India. Objectives To estimate the proportion of suspected cases classified as MIS-C and describe clinical features, severity, treatment and outcomes within the Indian Council of Medical Research (ICMR) National Clinical Registry for COVID-19. Methods Twelve tertiary hospitals in 11 states and union territories contributed to a registry extension, with retrospective review (April 2020-December 2022) and prospective surveillance (January 2023-June 2024). Cases were classified using the World Health Organization (WHO) definition, and analyses used the data available for each variable. Results Of 217 suspected cases, 41 (18.9%; 95% confidence interval 14.2-24.6%) were classified as MIS-C and 176 as not confirmed. Among confirmed cases, 43.9% were aged 0-4 years, 53.7% were aged 5-14 years, and 70.7% were male. Fever was universal; shock and respiratory features were more frequent than in not confirmed cases. Of 35 confirmed children with data, 21 (60.0%) required intensive care, and one of 41 died. Corticosteroids and intravenous immunoglobulin were administered to 65.9% and 61.0% of patients, respectively. Conclusion Extending an existing registry to paediatric departments provided a multicentric estimate among hospitalised suspected cases and a practical model for paediatric surveillance in resource-limited settings.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,000
OpenAlex ID: W7222232042
FWCI:
Cites: 27
Cited by:
Related to: 10